IL-23 has been recognized as a potent inflammatory cytokine and mediates arthritis progression by promoting the differentiation and maintenance of Th17 cells in conjunction with the release of IL-17, TNF, and IL-6 from Th17 cells, neutrophils, myeloid cells, and RA FLSs [3]. Here, IL37 is linked to arthritic joint disease.